Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

May 26, 1999

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

May 26, 1999

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

May 26, 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

May 26, 1999

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

May 25, 1999

SkyePharma announces U.S. launch of DepoCyt

May 25, 1999

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

May 25, 1999

K1-5 is a more potent angiogenesis inhibitor than angiostatin

May 25, 1999

MMP inhibitor MMI-270 tested in cancer patients in combination with 5-FU/folinic acid

May 24, 1999

Compounds in development at Shionogi reverse oncogene-induced cell transformation

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...